Cargando…

Seeing it through: translational validation of new medical imaging modalities

Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and phot...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldrich, Melissa B., Marshall, Milton V., Sevick-Muraca, Eva M., Lanza, Greg, Kotyk, John, Culver, Joseph, Wang, Lihong V., Uddin, Jashim, Crews, Brenda C., Marnett, Lawrence J., Liao, Joseph C., Contag, Chris, Crawford, James M., Wang, Ken, Reisdorph, Bill, Appelman, Henry, Turgeon, D. Kim, Meyer, Charles, Wang, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Optical Society of America 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345805/
https://www.ncbi.nlm.nih.gov/pubmed/22574264
http://dx.doi.org/10.1364/BOE.3.000764
_version_ 1782232157754753024
author Aldrich, Melissa B.
Marshall, Milton V.
Sevick-Muraca, Eva M.
Lanza, Greg
Kotyk, John
Culver, Joseph
Wang, Lihong V.
Uddin, Jashim
Crews, Brenda C.
Marnett, Lawrence J.
Liao, Joseph C.
Contag, Chris
Crawford, James M.
Wang, Ken
Reisdorph, Bill
Appelman, Henry
Turgeon, D. Kim
Meyer, Charles
Wang, Tom
author_facet Aldrich, Melissa B.
Marshall, Milton V.
Sevick-Muraca, Eva M.
Lanza, Greg
Kotyk, John
Culver, Joseph
Wang, Lihong V.
Uddin, Jashim
Crews, Brenda C.
Marnett, Lawrence J.
Liao, Joseph C.
Contag, Chris
Crawford, James M.
Wang, Ken
Reisdorph, Bill
Appelman, Henry
Turgeon, D. Kim
Meyer, Charles
Wang, Tom
author_sort Aldrich, Melissa B.
collection PubMed
description Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers.
format Online
Article
Text
id pubmed-3345805
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Optical Society of America
record_format MEDLINE/PubMed
spelling pubmed-33458052012-05-09 Seeing it through: translational validation of new medical imaging modalities Aldrich, Melissa B. Marshall, Milton V. Sevick-Muraca, Eva M. Lanza, Greg Kotyk, John Culver, Joseph Wang, Lihong V. Uddin, Jashim Crews, Brenda C. Marnett, Lawrence J. Liao, Joseph C. Contag, Chris Crawford, James M. Wang, Ken Reisdorph, Bill Appelman, Henry Turgeon, D. Kim Meyer, Charles Wang, Tom Biomed Opt Express Optics in Cancer Research Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers. Optical Society of America 2012-03-22 /pmc/articles/PMC3345805/ /pubmed/22574264 http://dx.doi.org/10.1364/BOE.3.000764 Text en ©2012 Optical Society of America http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially.
spellingShingle Optics in Cancer Research
Aldrich, Melissa B.
Marshall, Milton V.
Sevick-Muraca, Eva M.
Lanza, Greg
Kotyk, John
Culver, Joseph
Wang, Lihong V.
Uddin, Jashim
Crews, Brenda C.
Marnett, Lawrence J.
Liao, Joseph C.
Contag, Chris
Crawford, James M.
Wang, Ken
Reisdorph, Bill
Appelman, Henry
Turgeon, D. Kim
Meyer, Charles
Wang, Tom
Seeing it through: translational validation of new medical imaging modalities
title Seeing it through: translational validation of new medical imaging modalities
title_full Seeing it through: translational validation of new medical imaging modalities
title_fullStr Seeing it through: translational validation of new medical imaging modalities
title_full_unstemmed Seeing it through: translational validation of new medical imaging modalities
title_short Seeing it through: translational validation of new medical imaging modalities
title_sort seeing it through: translational validation of new medical imaging modalities
topic Optics in Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345805/
https://www.ncbi.nlm.nih.gov/pubmed/22574264
http://dx.doi.org/10.1364/BOE.3.000764
work_keys_str_mv AT aldrichmelissab seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT marshallmiltonv seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT sevickmuracaevam seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT lanzagreg seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT kotykjohn seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT culverjoseph seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT wanglihongv seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT uddinjashim seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT crewsbrendac seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT marnettlawrencej seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT liaojosephc seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT contagchris seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT crawfordjamesm seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT wangken seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT reisdorphbill seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT appelmanhenry seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT turgeondkim seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT meyercharles seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities
AT wangtom seeingitthroughtranslationalvalidationofnewmedicalimagingmodalities